ロード中...

Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

PURPOSE: Adjuvant! is a standardized validated decision aid that projects outcomes in operable breast cancer based on classical clinicopathologic features and therapy. Genomic classifiers offer the potential to more accurately identify individuals who benefit from chemotherapy than clinicopathologic...

詳細記述

保存先:
書誌詳細
主要な著者: Goldstein, Lori J., Gray, Robert, Badve, Sunil, Childs, Barrett H., Yoshizawa, Carl, Rowley, Steve, Shak, Steven, Baehner, Frederick L., Ravdin, Peter M., Davidson, Nancy E., Sledge, George W., Perez, Edith A., Shulman, Lawrence N., Martino, Silvana, Sparano, Joseph A.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2008
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2654377/
https://ncbi.nlm.nih.gov/pubmed/18678838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.14.4501
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!